Construction of a scoring model for evaluating the condition of adult allogeneic liver transplantation and predicting graft function based on coagulation/fibrinolysis molecular markers

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200065024

Enrollment

Unknown

Registered

2022-10-26

Start date

2022-11-01

Completion date

Unknown

Last updated

2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Transplantation

Interventions

cohort study:Obtain blood samples on ICU admission and 1, 3, and 5 days after surgery

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age >= 18 years old; 2. Allogeneic liver transplant patients with end-stage liver disease admitted to the intensive care unit after surgery

Exclusion criteria

Exclusion criteria: 1. History of renal insufficiency (dialysis or chronic kidney disease); 2. Multi-organ transplant patients

Design outcomes

Primary

Measure	Time frame
30-day mortality;Acute kidney injury;	—

Secondary

Measure	Time frame
Early allograft dysfunction(EAD);	—

Countries

China

Contacts

Public ContactGuojun

Sichuan University West China Hospital

328918116@qq.com+86 18980607186

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026